Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy von Diamantopoulos, Panagiotis T., Kontandreopoulou, Christina-Nefeli, Gkoufa, Aikaterini, Solomou, Elena, Anastasopoulou, Amalia, Palli, Eleni, Kouzis, Panagiotis, Bouros, Spyros, Samarkos, Mihalis, Magiorkinis, Gkikas, Gogas, Helen

Volltext